AG
GEN

Aperio Group’s Genesis Healthcare, Inc. GEN Stock Holding History

Aperio Group’s Portfolio GEN Stock Details GEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,363
Closed -$64K – 2034
2015
Q3 		$64K Buy
+10,363
New +$70.3K ﹤0.01% 1893
2015
Q2 		– Sell
-10,200
Closed -$73K – 2046
2015
Q1 		$73K Buy
+10,200
New +$76.9K ﹤0.01% 1933

Other funds holding GEN

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
CPA
Columbia Pacific Advisors Seattle, Washington $31M AUM 29.53% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return

Aperio Group's GEN Position: Q4 2015 in Review

Aperio Group sold out of Genesis Healthcare, Inc. (GEN) in Q4 2015, closing a stake of 10,363 shares — an estimated $64K sold.

Aperio Group first reported a position in GEN in Q1 2015 and held it in 2 quarters. The position peaked at $73K in Q1 2015. 82 funds tracked by Wall St. Rank hold GEN as of Q4 2015.

  • Aperio Group reported no remaining Genesis Healthcare, Inc. position as of Q4 2015 after selling out during the quarter.
  • Aperio Group sold 10,363 Genesis Healthcare, Inc. shares in Q4 2015, an estimated $64K.
  • Aperio Group first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 2 quarters.
  • Aperio Group's Genesis Healthcare, Inc. position peaked at $73K in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q4 2015.

Based on Aperio Group's 13F filing for Q4 2015, filed 21 Jan 2016.